Showing results (31-40 of 298) with videos related to
Sort By:
Pageof 30
Pharmacology & Therapeutics|October 13, 2017
Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infectionUlrich SpenglerJournal of Hepatology|January 23, 2009
Hepatic microcirculation: a critical but neglected factor for the outcome of viral hepatitisUlrich SpenglerTherapeutische Umschau. Revue Therapeutique|June 1, 2010
[Non adherence - non response in transplantation medicine]Ulrich SpenglerJournal of Hepatology|January 2, 2017
Increased peripheral CD4+ regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis CBettina Langhans, Hans Dieter Nischalke, Benjamin Krämer, et al.Journal of Hepatology|June 15, 2007
The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patientsGolo Ahlenstiel, Hans Dieter Nischalke, Karin Bueren, et al.Journal of Hepatology|August 31, 2010
HLA class I allele associations with HCV genetic variants in patients with chronic HCV genotypes 1a or 1b infectionChristian Markus Lange, Kirsten Roomp, Anette Dragan, et al.Current Opinion in HIV and AIDS|September 16, 2011
Management of end-stage liver disease in HIV/hepatitis C virus co-infectionUlrich SpenglerJournal of Hepatology|August 29, 2012
Susceptibility to chronic hepatitis C virus infection is influenced by sequence differences in immunodominant CD8+ T cell epitopesSusanne Ziegler, Marianne Ruhl, Hannelore Tenckhoff, et al.European Journal of Medical Research|May 11, 2010
The role of CCR5 in HCV infectionMartin Coenen, Jacob NattermannBest Practice & Research. Clinical Gastroenterology|October 20, 2010
Viral hepatitis: human genes that limit infectionFrank Grünhage, Jacob NattermannPageof 30